非侵襲的出生前診断の世界市場（～2026年）

• 英文タイトル：Global Noninvasive Prenatal Diagnostics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04005
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は非侵襲的出生前診断のグローバル市場について調査・分析したレポートです。種類別（サービス、機器）市場規模、用途別（病院、個人、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別非侵襲的出生前診断の競争状況、市場シェア
・世界の非侵襲的出生前診断市場：種類別市場規模 2015年-2020年（サービス、機器）
・世界の非侵襲的出生前診断市場：種類別市場規模予測 2021年-2026年（サービス、機器）
・世界の非侵襲的出生前診断市場：用途別市場規模 2015年-2020年（病院、個人、その他）
・世界の非侵襲的出生前診断市場：用途別市場規模予測 2021年-2026年（病院、個人、その他）
・北米の非侵襲的出生前診断市場分析：米国、カナダ
・ヨーロッパの非侵襲的出生前診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの非侵襲的出生前診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の非侵襲的出生前診断市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの非侵襲的出生前診断市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Natera、Illumina、BGI Diagnosis、Ariosa Diagnostics、Quest Diagnostics、Premaitha Health、NIPD Genetics、Labcorp、Ravgen、LifeCodexx、TrovaGene、Quest Diagnostics、Berry Genomics
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down’s syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.
North America has the largest share of the noninvasive prenatal diagnostics market, with Asia Pacific and the Middle East achieving the fastest growth.

Market Analysis and Insights: Global Noninvasive Prenatal Diagnostics Market
The global Noninvasive Prenatal Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Noninvasive Prenatal Diagnostics Scope and Market Size
Noninvasive Prenatal Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Noninvasive Prenatal Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Natera
Illumina
BGI Diagnosis
Ariosa Diagnostics
Quest Diagnostics
Premaitha Health
NIPD Genetics
Labcorp
Ravgen
LifeCodexx
TrovaGene
Quest Diagnostics
Berry Genomics

Market segment by Type, the product can be split into
Services
Instrument
Market segment by Application, split into
Hospital
Personal
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Noninvasive Prenatal Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Services
1.4.3 Instrument
1.5 Market by Application
1.5.1 Global Noninvasive Prenatal Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Personal
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Noninvasive Prenatal Diagnostics Market Perspective (2015-2026)
2.2 Global Noninvasive Prenatal Diagnostics Growth Trends by Regions
2.2.1 Noninvasive Prenatal Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Noninvasive Prenatal Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Noninvasive Prenatal Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Noninvasive Prenatal Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Noninvasive Prenatal Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Prenatal Diagnostics Players by Market Size
3.1.1 Global Top Noninvasive Prenatal Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Noninvasive Prenatal Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio
3.2.1 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Noninvasive Prenatal Diagnostics Revenue in 2019
3.3 Noninvasive Prenatal Diagnostics Key Players Head office and Area Served
3.4 Key Players Noninvasive Prenatal Diagnostics Product Solution and Service
3.5 Date of Enter into Noninvasive Prenatal Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Noninvasive Prenatal Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)
5.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Noninvasive Prenatal Diagnostics Market Size (2015-2020)
6.2 Noninvasive Prenatal Diagnostics Key Players in North America (2019-2020)
6.3 North America Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
6.4 North America Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Noninvasive Prenatal Diagnostics Market Size (2015-2020)
7.2 Noninvasive Prenatal Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
7.4 Europe Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)

8 China
8.1 China Noninvasive Prenatal Diagnostics Market Size (2015-2020)
8.2 Noninvasive Prenatal Diagnostics Key Players in China (2019-2020)
8.3 China Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
8.4 China Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Noninvasive Prenatal Diagnostics Market Size (2015-2020)
9.2 Noninvasive Prenatal Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
9.4 Japan Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Noninvasive Prenatal Diagnostics Market Size (2015-2020)
10.2 Noninvasive Prenatal Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)

11 India
11.1 India Noninvasive Prenatal Diagnostics Market Size (2015-2020)
11.2 Noninvasive Prenatal Diagnostics Key Players in India (2019-2020)
11.3 India Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
11.4 India Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Noninvasive Prenatal Diagnostics Market Size (2015-2020)
12.2 Noninvasive Prenatal Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Natera
13.1.1 Natera Company Details
13.1.2 Natera Business Overview
13.1.3 Natera Noninvasive Prenatal Diagnostics Introduction
13.1.4 Natera Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020))
13.1.5 Natera Recent Development
13.2 Illumina
13.2.1 Illumina Company Details
13.2.2 Illumina Business Overview
13.2.3 Illumina Noninvasive Prenatal Diagnostics Introduction
13.2.4 Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.2.5 Illumina Recent Development
13.3 BGI Diagnosis
13.3.1 BGI Diagnosis Company Details
13.3.2 BGI Diagnosis Business Overview
13.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Introduction
13.3.4 BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.3.5 BGI Diagnosis Recent Development
13.4 Ariosa Diagnostics
13.4.1 Ariosa Diagnostics Company Details
13.4.2 Ariosa Diagnostics Business Overview
13.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Introduction
13.4.4 Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.4.5 Ariosa Diagnostics Recent Development
13.5 Quest Diagnostics
13.5.1 Quest Diagnostics Company Details
13.5.2 Quest Diagnostics Business Overview
13.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
13.5.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.5.5 Quest Diagnostics Recent Development
13.6 Premaitha Health
13.6.1 Premaitha Health Company Details
13.6.2 Premaitha Health Business Overview
13.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Introduction
13.6.4 Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.6.5 Premaitha Health Recent Development
13.7 NIPD Genetics
13.7.1 NIPD Genetics Company Details
13.7.2 NIPD Genetics Business Overview
13.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Introduction
13.7.4 NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.7.5 NIPD Genetics Recent Development
13.8 Labcorp
13.8.1 Labcorp Company Details
13.8.2 Labcorp Business Overview
13.8.3 Labcorp Noninvasive Prenatal Diagnostics Introduction
13.8.4 Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.8.5 Labcorp Recent Development
13.9 Ravgen
13.9.1 Ravgen Company Details
13.9.2 Ravgen Business Overview
13.9.3 Ravgen Noninvasive Prenatal Diagnostics Introduction
13.9.4 Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.9.5 Ravgen Recent Development
13.10 LifeCodexx
13.10.1 LifeCodexx Company Details
13.10.2 LifeCodexx Business Overview
13.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Introduction
13.10.4 LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
13.10.5 LifeCodexx Recent Development
13.11 TrovaGene
10.11.1 TrovaGene Company Details
10.11.2 TrovaGene Business Overview
10.11.3 TrovaGene Noninvasive Prenatal Diagnostics Introduction
10.11.4 TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
10.11.5 TrovaGene Recent Development
13.12 Quest Diagnostics
10.12.1 Quest Diagnostics Company Details
10.12.2 Quest Diagnostics Business Overview
10.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
10.12.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
10.12.5 Quest Diagnostics Recent Development
13.13 Berry Genomics
10.13.1 Berry Genomics Company Details
10.13.2 Berry Genomics Business Overview
10.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Introduction
10.13.4 Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
10.13.5 Berry Genomics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Noninvasive Prenatal Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Noninvasive Prenatal Diagnostics Revenue
Table 3. Ranking of Global Top Noninvasive Prenatal Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Services
Table 6. Key Players of Instrument
Table 7. Global Noninvasive Prenatal Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Noninvasive Prenatal Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Noninvasive Prenatal Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Noninvasive Prenatal Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Noninvasive Prenatal Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Noninvasive Prenatal Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Noninvasive Prenatal Diagnostics Players
Table 18. Global Noninvasive Prenatal Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Noninvasive Prenatal Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Noninvasive Prenatal Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Prenatal Diagnostics as of 2019)
Table 21. Global Noninvasive Prenatal Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Noninvasive Prenatal Diagnostics Product Solution and Service
Table 24. Date of Enter into Noninvasive Prenatal Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Noninvasive Prenatal Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Noninvasive Prenatal Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Noninvasive Prenatal Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Noninvasive Prenatal Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Noninvasive Prenatal Diagnostics Market Share (2019-2020)
Table 34. North America Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Noninvasive Prenatal Diagnostics Market Share by Type (2015-2020)
Table 36. North America Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Noninvasive Prenatal Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Noninvasive Prenatal Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Noninvasive Prenatal Diagnostics Market Share (2019-2020)
Table 40. Europe Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Noninvasive Prenatal Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Noninvasive Prenatal Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Noninvasive Prenatal Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Noninvasive Prenatal Diagnostics Market Share (2019-2020)
Table 46. China Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Noninvasive Prenatal Diagnostics Market Share by Type (2015-2020)
Table 48. China Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Noninvasive Prenatal Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Noninvasive Prenatal Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Noninvasive Prenatal Diagnostics Market Share (2019-2020)
Table 52. Japan Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Noninvasive Prenatal Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Noninvasive Prenatal Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Noninvasive Prenatal Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Noninvasive Prenatal Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Noninvasive Prenatal Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Noninvasive Prenatal Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Noninvasive Prenatal Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Noninvasive Prenatal Diagnostics Market Share (2019-2020)
Table 64. India Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Noninvasive Prenatal Diagnostics Market Share by Type (2015-2020)
Table 66. India Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Noninvasive Prenatal Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Noninvasive Prenatal Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Noninvasive Prenatal Diagnostics Market Share (2019-2020)
Table 70. Central & South America Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Noninvasive Prenatal Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Noninvasive Prenatal Diagnostics Market Share by Application (2015-2020)
Table 74. Natera Company Details
Table 75. Natera Business Overview
Table 76. Natera Product
Table 77. Natera Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 78. Natera Recent Development
Table 79. Illumina Company Details
Table 80. Illumina Business Overview
Table 81. Illumina Product
Table 82. Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 83. Illumina Recent Development
Table 84. BGI Diagnosis Company Details
Table 85. BGI Diagnosis Business Overview
Table 86. BGI Diagnosis Product
Table 87. BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 88. BGI Diagnosis Recent Development
Table 89. Ariosa Diagnostics Company Details
Table 90. Ariosa Diagnostics Business Overview
Table 91. Ariosa Diagnostics Product
Table 92. Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 93. Ariosa Diagnostics Recent Development
Table 94. Quest Diagnostics Company Details
Table 95. Quest Diagnostics Business Overview
Table 96. Quest Diagnostics Product
Table 97. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 98. Quest Diagnostics Recent Development
Table 99. Premaitha Health Company Details
Table 100. Premaitha Health Business Overview
Table 101. Premaitha Health Product
Table 102. Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 103. Premaitha Health Recent Development
Table 104. NIPD Genetics Company Details
Table 105. NIPD Genetics Business Overview
Table 106. NIPD Genetics Product
Table 107. NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 108. NIPD Genetics Recent Development
Table 109. Labcorp Business Overview
Table 110. Labcorp Product
Table 111. Labcorp Company Details
Table 112. Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 113. Labcorp Recent Development
Table 114. Ravgen Company Details
Table 115. Ravgen Business Overview
Table 116. Ravgen Product
Table 117. Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 118. Ravgen Recent Development
Table 119. LifeCodexx Company Details
Table 120. LifeCodexx Business Overview
Table 121. LifeCodexx Product
Table 122. LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 123. LifeCodexx Recent Development
Table 124. TrovaGene Company Details
Table 125. TrovaGene Business Overview
Table 126. TrovaGene Product
Table 127. TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 128. TrovaGene Recent Development
Table 129. Quest Diagnostics Company Details
Table 130. Quest Diagnostics Business Overview
Table 131. Quest Diagnostics Product
Table 132. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 133. Quest Diagnostics Recent Development
Table 134. Berry Genomics Company Details
Table 135. Berry Genomics Business Overview
Table 136. Berry Genomics Product
Table 137. Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020) (Million US$)
Table 138. Berry Genomics Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Prenatal Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Services Features
Figure 3. Instrument Features
Figure 4. Global Noninvasive Prenatal Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Personal Case Studies
Figure 7. Other Case Studies
Figure 8. Noninvasive Prenatal Diagnostics Report Years Considered
Figure 9. Global Noninvasive Prenatal Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Noninvasive Prenatal Diagnostics Market Share by Regions: 2020 VS 2026
Figure 11. Global Noninvasive Prenatal Diagnostics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Noninvasive Prenatal Diagnostics Market Share by Players in 2019
Figure 14. Global Top Noninvasive Prenatal Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Prenatal Diagnostics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Noninvasive Prenatal Diagnostics Revenue in 2019
Figure 16. North America Noninvasive Prenatal Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Noninvasive Prenatal Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Noninvasive Prenatal Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Noninvasive Prenatal Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Noninvasive Prenatal Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Noninvasive Prenatal Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

出生前検査の世界市場（～2026年）

Global Prenatal Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY04361 2020年11月20日 91Pages
当調査資料は出生前検査のグローバル市場について調査・分析したレポートです。種類別（第1期スクリーニング検査、第2期スクリーニング検査、第3期スクリーニング検査、診断検査）市場規模、用途別（病院、病理学研究室、婦人科クリニック、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

出生前遺伝子検査の世界市場（～2026年）

Global Prenatal Genetic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY04360 2020年11月20日 97Pages
当調査資料は出生前遺伝子検査のグローバル市場について調査・分析したレポートです。種類別（診断検査、絨毛採取（CVS）、羊水穿刺、胎盤生検、臍帯穿刺、胎児生検、スクリーニング検査、キャリアスクリーニング、順次スクリーニング、母体血清クワッドスクリーニング）市場規模、用途別（病院、診療所、診断センター）...

出生前・新生児遺伝子検査の世界市場（～2026年）

Global Prenatal and Newborn Genetic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY04359 2020年11月20日 130Pages
当調査資料は出生前・新生児遺伝子検査のグローバル市場について調査・分析したレポートです。種類別（アレイ比較遺伝子ハイブリダイゼーション（aCGH）、蛍光in-situハイブリダイゼーション（FISH）、ポリメラーゼ連鎖反応（PCR））市場規模、用途別（病院、診断機関、その他）市場規模、地域別（北米、...

非侵襲的出生前検査（NIPT）の世界市場（～2026年）

Global Non-Invasive Prenatal Testing (NIPT) Market Size, Status and Forecast 2020-2026
MRC2-11QY04006 2020年11月20日 99Pages
当調査資料は非侵襲的出生前検査（NIPT）のグローバル市場について調査・分析したレポートです。種類別（超音波、NGS、PCR、マイクロアレイ）市場規模、用途別（病院、診断ラボ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

出生前・胎児・新生児用機器の世界市場（～2026年）

Global Prenatal, Fetal and Neonatal Equipment Market Size, Status and Forecast 2020-2026
MRC2-11QY04362 2020年11月20日 133Pages
当調査資料は出生前・胎児・新生児用機器のグローバル市場について調査・分析したレポートです。種類別（出生前および胎児用機器、超音波および超音波検査装置、胎児ドップラー、胎児磁気共鳴画像法、胎児モニター、新生児用機器、乳児用加温器および保育器、光線療法機器、新生児用監視装置、呼吸補助および監視装置）市場...

妊婦用ビタミンサプリメントの世界市場（～2026年）

Global Prenatal Vitamin Supplements Market Insights and Forecast to 2026
MRC2-11QY14328 2020年11月30日 115Pages
当調査資料は妊婦用ビタミンサプリメントのグローバル市場について調査・分析したレポートです。種類別（ビタミンA、ビタミンD、ビタミンE、その他）市場規模、用途別（小売店、直接販売、オンライン）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

出生前教育機器の世界市場（～2026年）

Global Prenatal Education Instrument Market Insights and Forecast to 2026
MRC2-11QY14327 2020年11月30日 115Pages
当調査資料は出生前教育機器のグローバル市場について調査・分析したレポートです。種類別（心音教室、音楽言語カテゴリー）市場規模、用途別（0〜3ヶ月、3〜8ヶ月、8〜10ヶ月、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

女性健康診断の世界市場（～2026年）

Global Women Health Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY05114 2020年11月20日 125Pages
当調査資料は女性健康診断のグローバル市場について調査・分析したレポートです。種類別（乳がん検査、子宮頸がん検査、骨粗鬆症検査、妊娠検査、受精能検査、卵巣がん検査、感染症検査、出生前遺伝子スクリーニングおよび保菌検査、超音波検査、HIV検査）市場規模、用途別（診断および画像センター、病院および診療所、...

マタニティベルトの世界市場（～2026年）

Global Prenatal Belts Market Insights and Forecast to 2026
MRC2-11QY14326 2020年11月30日 118Pages
当調査資料はマタニティベルトのグローバル市場について調査・分析したレポートです。種類別（ナイロン、スパンデックス、綿、その他）市場規模、用途別（スーパー＆モール、ブランド店、オンライン）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

食品診断用PCRシステムの世界市場（～2026年）

Global PCR System for Food Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY04189 2020年11月20日 95Pages
当調査資料は食品診断用PCRシステムのグローバル市場について調査・分析したレポートです。種類別（消耗品、機器）市場規模、用途別（製造業、化学品、食品・飲料、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

出生前検査の世界市場（～2026年） Prenatal testing consists of prenatal screening and prenatal diagnosis, which are aspects of prenatal care that focus on detecting problems with the pregnancy as early as possible. Prenatal screening can detect problems such as neural tube defects, chromosome abnormalities, and it can also detect an…
出生前遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prenatal Genetic Testing Scope and Market Size Prenatal Genetic T…
出生前・新生児遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Prenatal and Newborn Genetic Testing Market The global Prenatal and Newborn Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prenatal and Newborn Genetic Testing Scop…
出生前教育機器の世界市場（～2026年） Market Analysis and Insights: Global Prenatal Education Instrument Market The global Prenatal Education Instrument market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prenatal Education Instrument Scope and Market Size Pre…
非侵襲的出生前検査（NIPT）の世界市場（～2026年） The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age. Asia is expected to grow at the highest CAGR during the…